Cargando…
Folic Acid-Targeted Disulfide-Based Cross-Linking Micelle for Enhanced Drug Encapsulation Stability and Site-Specific Drug Delivery Against Tumors [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612087/ https://www.ncbi.nlm.nih.gov/pubmed/34848954 http://dx.doi.org/10.2147/IJN.S347786 |
Ejemplares similares
-
Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors
por: Zhang, Yumin, et al.
Publicado: (2016) -
Corrigendum to “Drug Delivery Nanoparticles in Skin Cancers”
por: Dianzani, Chiara, et al.
Publicado: (2021) -
Factors determining the stability, size distribution, and cellular accumulation of small, monodisperse chitosan nanoparticles as candidate vectors for anticancer drug delivery: application to the passive encapsulation of [(14)C]-doxorubicin [Corrigendum]
Publicado: (2016) -
Redox-Responsive Comparison of Diselenide and Disulfide Core-Cross-Linked Micelles for Drug Delivery Application
por: Yadav, Sonyabapu, et al.
Publicado: (2023) -
A Versatile Polymer Micelle Drug Delivery System for Encapsulation and In Vivo Stabilization of Hydrophobic Anticancer Drugs
por: Rios-Doria, Jonathan, et al.
Publicado: (2012)